LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent Glioblastoma

NCT04479241 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma
Recurrent Glioblastoma
Supratentorial Glioblastoma
Brain Tumor

Interventions

BIOLOGICAL: lerapolturev
BIOLOGICAL: pembrolizumab

Sponsor

Istari Oncology, Inc.